Amedisys price target raised by $3 at RBC Capital, here's whyThe Fly • about 1 month ago
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Share to Feed
In a report released today, Gary Taylor from TD Cowen maintained a Hold rating on Amedisys (AMED Research Report), with a price target of $101.00...
Amedisys Non-GAAP EPS of $0.94 misses by $0.05, revenue of $570.8M misses by $0.83M...
BATON ROUGE, La., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2023. Three-Month...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
BATON ROUGE, La., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is now offering advanced molecular...
This price move could indicate a change in the trend, and may be a buy signal for investors...
This price move could indicate a change in the trend, and may be a buy signal for investors...
This price move could indicate a change in the trend, and may be a sell signal for investors...
This is a Bullish indicator signaling AMED's price could rise from here. Traders may explore going long the stock or buying call options...